化痰安神熄风法对高血压病疗效和生化指标影响的临床研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
高血压病是人类心血管疾病中发病率最高的一种疾病。据报道,仅高血压可导致全球30%的心血管病患者死亡。近年来,我国高血压病患病率呈逐年上升趋势,目前大约有1.6亿高血压病患者。高血压及其相关疾病不仅影响着患者的生活质量,给家庭及社会带来沉重的负担,而且由此带来的医疗费用更是惊人。如何有效控制和治疗高血压已成为当今的一个重要课题。
     研究发现,痰湿壅盛是高血压病的主要证型之一,而分析现代人的工作和生活特点,发现“精神紧张”亦是高血压病发病的病机之一。从其发病机制上,国内外学者研究发现慢性炎症在高血压的发病率上扮演重要角色,高血压与血浆中C反应蛋白水平、组织坏死因子alpha等有关。
     研究目的:应用化痰安神熄风法治疗痰湿壅盛型高血压病患者,观察该法对痰湿壅盛型高血压病患者疗效及生化指标的影响。
     研究方法:选取符合纳入标准的高血压病患者共100例,采用简单随机化原则分治疗组、对照组各50例。对照组采用西医基础治疗,治疗组则采用西医基础治疗加中医化痰安神熄风法(自拟化痰安神熄风方)治疗,各组治疗时间均为60天。观察治疗前后两组痰湿壅盛证积分、血压、心率、血脂、尿酸、空腹血糖、空腹胰岛素、C反应蛋白的变化,并进行比较。
     结果:1.治疗后治疗组痰湿壅盛证积分较对照组明显改善(P=0.000);治疗后治疗组痰湿壅盛证疗效评定优于对照组(P=0.000)。
     2.治疗后治疗组与对照组的血压均有改善,治疗组的血压改善优于对照组(收缩压治疗后组间比较P=0.000,舒张压治疗后组间比较P=0.049);治疗后治疗组的心率较对照组明显改善(P=0.000)。
     3.治疗后治疗组的空腹血糖、空腹胰岛素、CRP均较对照组明显改善(P分别为0.001、0.000、0.000);尿酸、TC、LDL-C、HDL-C虽与对照组比较无显著性差异(P>0.05),但自身前后比较差异有显著性(P均为0.000)。TG治疗前组间比较有统计学差异(P=0.049),故没有可比性。
     结论:在西医治疗的基础上,化痰安神熄风法能更好改善痰湿壅盛型高血压病患者的血压和心率,降低C反应蛋白水平,并可能对血脂、尿酸有一定的改善作用。
Essential hypertension(EH)is a disease whose incidence is highest in Cardiovascular Diseases(CVD).It is reported that only hypertension can make 30 percent patients of CVD in the world die.In the past few years, the incidence of EH has climbed year after year.At now,there are about 160 million patients of EH in our country.Hypertension and its correlated diseases not only influence patients' living quality,and brings heavy burden on family and society,but also brings horrifying cost of medical treatment.How to control and treat hypertension effectively has been an important discussion today.
     It was found that accumulation of phlegm-wetness is one of major syndromes of EH.And mental stress is one of pathogenesis on incidence of EH through analyzing people's characteristic in working and life today.On the pathogenesis of EH,the scholars at home and abroad studies find that chronic inflammation plays an important role of incidence of EH,and hypertension is related to C-reactive protein and necrosis factor-alpha.
     Objective:To treat patients of EH with accumulation of phlegm-wetness with the therapeutic method of eliminating phlegm, tranquilizing and calming wind,then to observe effectiveness of EH and influence on biochemical parameters.
     Methods:Select 100 cases of EH according to the standard which the patients of EH are brought into.It is randomly divided into 2 groups which are given the same basic Western treatment.50 cases are in treatment group, and 50 cases in control group.The therapeutic method of eliminating phlegm,tranquilizing and calming wind(with recipe of eliminating phlegm, tranquilizing and calming wind)is given to the treatment group.The course of treatment of every group is 60 days.Grade of phlegm-wetness syndrome,blood pressure(BP),rhythm of the heart(HR),fat in blood,uric acid(UA),blood-glucose,fasting Insulin and C-reactive protein of every group are observed respectively before and after treatment,and then to compare.
     Results:1.After treatment,the grade and the curative effect of phlegm-wetness syndrome in the treatment group have been improved notably in comparison with those in the control group(the former P=0.000,the latter P=0.000).
     2.The BP in every group have been improved after treatment, and the BP in the treatment group has been improved more than that in the control group(SBP P=0.000,DBP P=0.049).the HR in the treatment group has been also improved notably than that in the control group(P=0.000).
     3.After treatment,the blood-glucose,fasting insulin and C-reactive protein in the treatment group have been improved notably in comparison with those in the control group(the former P=0.001,the latter two P=0.000).The UA,TC,LDL-C and HDL-C in the treatment group after treatment have been improved in comparison with those before treatment (all P=0.000),but haven't significant difference in statistics in comparison with the control group(P>0.05).Because there is significant difference of TG between the two groups before treatment,there is no significance to contrast after treatment.
     Conclusion:On the basis of Western treatment,the therapeutic method of eliminating phlegm,tranquilizing and calming wind can improve the BP,HR and C-reactive protein more satisfactorily in the patients of EH with accumulation of phlegm-wetness.And it can probably improve the fat in blood and UA to a certain extent.
引文
[1]Bautista hE.Inflammation,endothelial dysfunction,and the risk of high blood pressure:epidemiologic and biological evidence.J Hum-Hypertens,2003,17(4):223-230
    [2]广东省糖尿病流行病学调查协作组.广东省高血压流行趋势和控制现况.广东医学,2002,23(3):299-301
    [3]顾东风.心血管疾病预防的现状和展望.中华预防医学杂志,2003,17(2):75-76
    [4]中国高血压防治指南修订委员会.中国高血压防治指南.2005
    [5]上海市高血压研究所.高血压病.上海:上海科学技术出版社,1978,138
    [6]王裕顺,牛天富.高血压病人24小时动态血压与中医证型关系的观察.中国医药学报,1993,8(5):15
    [7]徐贵成,徐承秋,张大革.平肝益肾法治疗Ⅱ期高血压病的临床研究.北京中医,1991,4(6):21
    [8]高飞.国际中医心病学术会议述要.中国医药学报,1993,8(2):53
    [9]钟志美.高血压病分型及治法.新中医,1996,28(11):61-62
    [10]葛红霞.老年高血压病的证治体会.南京中医药大学学报,1996,12(6):54-55
    [11]傅仁杰.老年高血压病的辨证论治.中医杂志,1993,34(8):495
    [12]冯桂贞,吕崇山.高血压病辨证论治中若干问题的探讨.福建中医学院学报,2001,11(4):9-10
    [13]王晓光,陈宝田.84例老年性高血压病中医辨证分型及治疗规律探讨.实用中西医结合杂志,1995,8(7):410
    [14]金益强,胡随瑜,鄢东红,等.高血压肝阳上亢证的分子机理研究.中国中西医结合杂志,2000,20(2):87-90
    [15]张玲端,刘淑云,白智峰,等.原发性和肾性高血压中医证候衍变规律及实质的探讨.辽宁中医杂志,1992,(9):18-21
    [16]王爱珍,蔡治宾,吴罗杰.原发性高血压中医辨证分型与肾素血管紧张素Ⅱ初探.中国现代医学杂志,1998,8(5):43
    [17]郑峰,胡世云,孙光,等.Ⅱ期高血压病中医证型与血浆内皮素一氧化氮关系的临床研究.福建中医药,2000,31(2):5-7
    [18]吴辉,冼绍祥,黄衍寿.血管活性物质与原发性高血压中医证型的关系.四川中医,2000,18(10):11-12
    [19]唐树德.高血压患者辨证分型与肾素-血管紧张素-醛固酮系统的关系.辽宁中医杂志,1985,9(12):4
    [20]静文英.原发性高血压病患者肾素-血管紧张素值与中医辨证的关系.中西医结合杂志,1988,8(11):663
    [21]吴奕强,罗治华,唐荣德,等.高血压病的血液流变学变化与中医辨证分型的关系.新中医,1994,26(3):10
    [22]黄俊山,白介辰,黄国良,等.高血压病患者血清胰岛素、C肽水平与中医辨证分型的关系.中国中西医结合杂志,2000,20(3):190-191
    [23]蒋卫民,唐蜀华,陈晓虎.高血压病辨证分型与胰岛素抵抗关系的初步研究.中国中医基础医学杂志,1998,4(11):37-39
    [24]刘惠文,张铁忠,李光伟,等.高血压病患者胰岛素抵抗与中医辨证分型的相关性研究.中国中西医结合杂志,1999,19(4):200-202
    [25]吴启锋,熊尚全,温茂详,等.高血压病中医证型与胰岛素抵抗关系临床研究.福建中医药,2001,32(6):3-4
    [26]张玉金,张文芝.高血压病辨证分型和胰岛素抵抗关系的探讨.河南中医,2001,21(1):35-37
    [27]贺燕勤.高血压病中医证型与胰岛素抵抗、脂质及红细胞膜ATP酶活性的关系.中医研究,1999,12(5):18-20
    [28]潘仰中,蔡运昌,邓绍宜,等.原发性高血压左室舒张功能与中医辨证分型关系的研究.中国中西医结合杂志,2000,20(6):436-437
    [29]王莉娅,张捷,朱丽华,等.高血压病患者P波终末电势与中医证型的关系.南京中医药大学学报(自然科学版),2000,16(1):20-21
    [30]王学美,富宏,刘庚信.高血压病中医辨证分型与T淋巴细胞亚群及NK细胞相关性的研究.中国中西医结合急救杂志,2000,7(3):174-175
    [31]郭惠君.高血压病与血淤证.北京中医,1995,(2):60
    [32]孔炳耀.中医法则在高血压病临床的应用概况.上海中医药杂志,1996,(8):13
    [33]曾树贞.滋补肝肾、益气养阴法治疗眩晕62例.广西中医药,1994,(4):14
    [34]李素文.中医治疗眩晕病55例临床观察.广西中医药,1984,(4):25-26
    [35]崔永顺,等.辨证治疗老年眩晕证46例临床报告.黑龙江中医药,1989,(3):15-16
    [36]刘桂秋,等.中医辨证分型治疗眩晕病.湖南医药杂志,1984,(4):47
    [37]邵继堂.钩藤七味饮治风痰眩晕18例小结.黑龙江中医药,1984,(3):35
    [38]徐贵成,张流成.活血降压方治疗高血压病102例.北京中医,1994,13(2):26
    [39]姚国愣.小续命汤加减治疗高血压病.上海中医药杂志,1994,28(5):7
    [40]张培英.原发性高血压辨治探要.山东中医杂志,1999,18(11):483-484
    [41]张治愈,杨秀坤,杨之松,等.轻剂泻下利水法治疗高血压病138例临床观察. 中医药研究,1996,12(5):42-43
    [42]朱文玉.泽泻降压汤治疗高血压病104例临床观察.中西医结合杂志,1984,4(9):521
    [43]鞠大宏,韩学杰,谢雁鸣,等.高血压病从络论治探讨.中国中医基础医学杂志,2001,7(9):43
    [44]李格,史载详,柳翼,等.熄风化痰法治疗高血压急性脑出血57例临床观察.中医杂志,2002,43(6):433-434
    [45]严灿,高敏,邓中炎,等.高血压病左心室肥厚患者血浆P物质水平的变化及活血祛痰治法的影响.中国中西医结合杂志,1998,18(6):336-338
    [46]严冬,蒋卫民,唐蜀华.降压益肾颗粒治疗高血压病早期肾损害35例疗效观察.中医药研究,1999,15(1):6-7
    [47]宋朝功.养心安神止眩丸对心理应激致高血压病的疗效观察.中西医结合心脑血管病杂志,2004,2(6):366-367
    [48]林晓晖.调整阴阳对改善高血压病患者血压昼夜节律及夜间睡眠的临床研究.现代医院,2005,5(7):80-81
    [49]刘亦选,冼绍祥,刘小虹.1239例原发性高血压证治规律分析.新中医,1993,25(10):20-23
    [50]刘小斌.邓铁涛教授诊疗经验整理研究.新中医,1998,30(3):6-7
    [51]罗致强.调气血为主治疗老年高血压病.中医杂志,1993,34(8):495
    [52]罗瑞林.自拟丹参钩藤汤为主治疗原发性高血压312例疗效观察.安徽中医临床杂志,1998,10(6):365
    [53]刘海林.自拟桂石降压汤治疗高血压病187例.中医药信息,1996,(4):22
    [54]刘敬东.加味地黄汤治疗高血压病60例临床观察.湖南中医杂志,1993,9(6):5
    [55]马培江.降压宁胶囊治疗512例原发性高血压临床观察报告.北京中医,1997,16(5):27
    [56]周文泉.长生降压液对老年肾虚证高血压病的影响.中国中西医结合杂志,1995,15(9):532
    [57]陆曙.降防保心片对高血压左室肥厚影响的临床研究.南京中医药大学学报,1998,14(1):16
    [58]刘玉琴.补中益气汤治疗原发性高血压15例.北京中医,1991,(6):15
    [59]张权斌.大剂量黄芪治疗高血压病15例.实用中西医结合杂志.1991,4(10):629
    [60]刘华.仙柏补阳还五汤治疗肾气虚血瘀型高血压病的临床研究.中国中西医结合杂志,1993,13(2):714
    [61]文茂森.川芎泽泻散治疗高血压病80例.陕西中医,1997,18(9):393
    [62]唐树德,王宪衍,王崇行,等。首乌治疗早期肾脏损害血瘀型高血压患者28例.中国中西医结合杂志,1994,14(5):302-303
    [63]冯培芳,倪海祥,方若莹,等.三七总皂甙改善高血压病左室舒张功能的临床研究.浙江中西医结合杂志,1996,6(2):65-66
    [64]吴寿岭,高竞生,郝冰,等.血清高敏C反应蛋白浓度与高血压病的相关性研究.中华心血管病杂志,2003,31(12):917-920
    [65]汪朝晖,廖玉华.如何评价心血管病中的炎症因子与炎症标志物.临床心血管病杂志,2007,23(1):1-2
    [66]秦树存,王士雯.细胞因子与动脉粥样硬化.国外医学·老年学分册,1994,15(5):193
    [67]杨兰泽,高静,谢顺清,等.老年心血管疾病患者细胞因子水平的变化.中国老年学杂志,2005,25(3):331-332
    [68]刘倩.肿瘤坏死因子-α、内皮素与高血压病的关系探讨.西部医学,2004,1,53-54
    [69]LIAO Y H,WEI Y M,WANG M,et al.Autoantibodies against AT1-receptor and α 1-adrenergic receptor inpatients with hypertension.Hypertens Res,2002,25:641-646
    [70]李大主,周游,吴伟,等.负载热休克蛋白60的致耐受性树突状细胞疫苗对小鼠动脉粥样硬化斑块的影响.中国病理生理杂志,2006,22(6):1079-1082
    [71]FORD P,GEMMELL E,WALKER P,et al.Characterization of heat shock protein-specific T cell in atherosclerosis.Clin Diagn Lab Immunol,2005,12:259-267
    [72]袁洪,李轶男,张梦玺.老年高血压病患者血管内皮损伤、血小板活化及炎症因子的改变.中国动脉硬化杂志,2001,9(3):255-256
    [73]谭元生,张稳.原发性高血压病人血管性假血友病因子及超敏C反应蛋白的检测意义.中西医结合心脑血管病杂志,2007,9:30-31
    [74]张敏,马虹.C反应蛋白水平与高血压女性患糖代谢异常的危险性眼睛-附514例分析.新医学,2004,35(3):147-149
    [75]郭旭昌,阴爱珍.原发性高血压并高尿β2微球蛋白患者与C反应蛋白的关系及其意义的研究.现代检验医学杂志,2004,19(5):25-26
    [76]王强,黎芳,方显明.天麻钩藤饮合卡托普利对高血压病患者血压及炎症因子的影响.中医杂志,2008,1:38-40
    [77]姚祖培,陈建新,喻海忠.化瘀复元胶囊对高血压病病人血清炎症细胞因子的影响.中西医结合心脑血管病杂志,2008,1:10-11
    [78]张小卫,余静,常鹏.黄芪注射液对高血压病患者炎症介质的影响.兰州大学学报(医学版),2007,4:52-54
    [79]莫雪妮,杨益宝,黄绍湘.C-反应蛋白与高血压病的关系.现代中西医结合杂志,2005,14(19):2612-2613
    [80]蔡光先,朱克俭.高血压常见证候临床流行病学观察.中医杂志,1999,40(8):492-493
    [81]陈利国,尤可.中西医结合内科治疗学.北京:人民军医出版社,1999,95-104
    [82]王健,盛净,杨菊贤.帕罗西汀对原发性高血压伴心理障碍患者降压疗效的影响.中国行为医学科学,2000,9(4):273-274
    [83]杨永良.中药学.湖北:湖北科学技术出版社,1989,64,110,186,215,225
    [84]张俊荣.岭南中草药撮要.广东:广东高等教育出版社,1994,16,558
    [85]王慧,周华珠,李弘磊.养心1号抗,bN应激作用的实验研究.徐州医学院学报,1996,16(4):417-419
    [86]方永奇,黄可儿,李小兵.痰证的血液循环特征初探.湖北中医杂志,1992,14(6):33-34
    [87]李运伦.高血压病与痰证.山东中医药大学学报,2000,24(6):412-414
    [88]江苏新医学院.中药大辞典·上册(缩印本).上海:上海科学技术出版社,1994,775
    [89]江苏新医学院.中药大辞典·上册(缩印本).上海:上海科学技术出版社,1994,1462
    [90]张玲瑞,刘淑云,白智峰,等.原发性和肾性高血压中医证候演变规律及实质探讨.辽宁中医杂志,1992,19(9):18
    [91]袁成民.八物降压冲剂治疗原发性高血压的临床与实验研究.山东中医药大学学报,1999,23(3):38
    [92]高喜源.高血压病中医辨证心钠素肾素血管紧张素醛固酮系统的测定.实用中西医结合杂志,1998(12):1059
    [93]吕萍,李自成,孙蓓,等.C反应蛋白与高血压病关系探讨.广东医学,2003,24(3):256
    [94]Ichtlscherer S,Rosenberer G,Dirk H,et al.Elevated C-reactive Protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease.Circulation,2000,102(13):1000-1006
    [95]Bhagat K,Vallance P.Inflammatory cytokines impair endothelium dependent dilation in human veins in vivo.Circulation,1997,96(1):3042-3047
    [96]Hayaishr Okano R,Yamsaki Y,Katakami N,et al.Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.Diabetes Care,2002,25(5):1432-1438
    [97]Yasunari K,Maeda K,Nakamura M,et al.Oxidative stress in Leukocytes is a possible link between blood glucose,and C-reactive protein.Hypertension,2002,39(1):777-780
    [98]杨胜利,何秉贤.C-反应蛋白与冠心病.中华心血管病杂志,2001,29(1):187-188
    [99]孙建芝,牛晓亚,韩丽华,等.痰浊证微观辨证标准的实验研究.河南中医,1996,16(2):21-22

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700